Rojastin Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Pharmaking Co., Ltd.
MFDS item code 201400395 · Approved 2014.01.28
This product's status changed to Expired on 2024.01.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is primarily used as an adjunct in patients with primary hypercholesterolemia and mixed hyperlipidemia when dietary changes and exercise alone are insufficient. It is also helpful for patients with homozygous familial hypercholesterolemia in conjunction with dietary measures and LDL apheresis. It significantly contributes to lowering total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. Additionally, it is used as an adjunct in the dietary management of primary dysbetalipoproteinemia. In men over 50 years old and women over 60 years old with elevated high-sensitivity C-reactive protein levels, it helps reduce the risk of stroke, myocardial infarction, and vascular revascularization procedures. It is an effective therapeutic agent for reducing the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 5. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this drug is contraindicated in some of these patients.
This medication should not be administered to certain patients. Patients with allergies to any component of this medication, those with severe liver impairment, those with muscle diseases, patients taking certain medications, those with severe kidney dysfunction, and women who are pregnant or breastfeeding should not take this medication. Additionally, this medication contains lactose and caution should be exercised in patients with lactose intolerance. Patients taking this medication should have liver function and muscle status monitored regularly, especially those who consume alcohol in excess or have a history of liver disease. If symptoms such as muscle pain or weakness occur, medical personnel should be notified immediately, and in severe cases, discontinuation of the medication may be warranted. Moreover, this medication may interact with other drugs, hence current medications must be disclosed, as concomitant use of certain drugs may increase the risk of muscle damage. Women who may become pregnant must use appropriate contraception and should not take this medication during pregnancy. In the case of overdose, there are no specific antidotes, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. Finally, this medication can cause symptoms like dizziness, so caution is needed when driving or operating machinery.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal bloating, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to store the medication at room temperature, between 1°C and 30°C, avoiding extremes of temperature.
Pink round film-coated tablet
28 tablets/PTP (14 tablets/PTP × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Pharmaking Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.